This message was sent to ##Email##
Registration for the ASHI 43rd Annual Meeting being held at the Hilton San Francisco Union Square on September 11-15, 2017 is open!
Click here to download the complete registration brochure!
Click here to view more information regarding registration rates and how to register today!
Don't forget to renew your 2017 membership before registering for the 43rd Annual Meeting!
Click here to renew your 2017 membership now!
Book Your Hotel Now!
Housing is now available for the ASHI 43rd Annual Meeting in San Francisco. Housing is available on a first-come, first-served basis. Book your housing today to guarantee your room!
Click here for more information on hotel room rates and how to book online.
Please note that for the first time, the ASHI Annual Meeting will be a paperless event. The meeting program will be available online only. Please download and print the program (also available on the ASHI website) if you prefer a personal copy. Thank you for helping us reduce our carbon footprint!
The pocket schedule at a glance will still be available thanks to our generous sponsor, One Lambda, a Thermo Fisher Scientific Brand.
Join us Thursday evening, September 14th from 9-11 p.m. for an evening of networking & fun with fellow attendees and dancing the night away with DJ Dorry. Click here to submit a song request!
The Networking Event is included in your registration fee!
The ASHI Board of Directors Membership Engagement Task Force is promoting the development and financial support of local HLA meetings. The main goal of this effort is to engage technologists in inter-laboratory learning activities. ASHI is facilitating this activity by providing guidance on the process to develop a local meeting as well as by providing up to $1,000 in funding to assist with local meeting planning and conduct. We created an ASHI Local Meeting Handbook to assist you in the process of setting up your meeting. Included in the handbook are:
We encourage you to work with laboratories in your area to begin planning your meeting and to submit an application. All applications will be reviewed on a rolling basis and funding is available now!
- Local Meeting Start Up Guide Overview
- Local Meeting Request Form
- Sample Meeting Agenda
- Post Event Requirements
- Photo Release Form
- ABHI Approved Provider Request Form
- ABHI Accepted CE Activities
- ABHI Provider Fee Schedule
If you are interested in coordinating a local HLA meeting for your lab, submit the completed form to email@example.com.
Or you can complete the online application form.
- Are you processing too many samples? Automate cell isolations with RoboSep™: TAKE PRODUCT TOUR
- Development of a rapid optimized flow cytometry crossmatch (FCXM) assay: READ CASE STUDY
- Learn about fast isolation of lymphoid and myeloid cells for use in lineage-specific chimerism analysis: VIEW POSTERS
- Are you assessing cell samples via flow cytometry? Here are some considerations for FACS gating: READ TECH TIP
- Frequencies of cell types in human peripheral blood: REQUEST WALLCHART
Name & Credentials: Caroline Raasch Alquist, MD, PhD
Job title and place of employment: Physician, Medical Director, Director in Training, Transfusion Medicine Service
Graduated from: Dartmouth Hitchcock Medical Center Transfusion Medicine Fellowship
How long have you been an ASHI member? Since 2015
If you would like to be featured in an upcoming Member Spotlight, please complete the online form.
With our busy lives, it can be hard to find time to volunteer, however, the right match can help you find friends, learn new skills, and even advance your career. Volunteering can also help improve your mental and physical health. Learn more about the many benefits of volunteering and get started as a ASHI volunteer by visiting the online Volunteer Portal on the ASHI website. Here you will find open committee positions as well as micro-volunteering opportunities.
CURRENT VOLUNTEER OPPORTUNITIES
- Be available at the Membership Desk
- Volunteer at the 5K
- Collect tickets at the pre-meeting on Monday
- Hand out agendas for the business meeting, Directors' and Technologists' Forums
2 Committee Vacancies
Directors' Affairs Committee
- During Public Comment Period, review proposed changes to the bylaws and respond with comments
3 Committee Vacancies
- Posting to Online Directors' Forum
- Being a meeting buddy for a director in training
- Being a mentor
3 Committee Vacancies
- Reviewing an ASHI U module
- Writing an ASHI U module
- Being a moderator for a regional education workshop
- Writing a case study for the regional education workshop
4 Committee Vacancies
Proficiency Testing Committee
- Help at the registration desk &/or membership table at annual meeting
- Help with evaluating membership survey questions for ASHI Membership Survey (to be ready for review by 3rd Quarter)
If there are any open committee positions, they will be posted after the annual meeting.
- Posting to online Directors' forum
- Posting to online Technologists' forum
- Editing content for Quarterly
- Serving as Quarterly content coordinator (coordinator would suggest content and/or track writers, editors, and deadlines for the upcoming issues, etc.)
3 Committee Vacancies
Quality Assurance and Standards Committee
- Review of ASHI U modules/development of modules
- Review of current literature to offer suggestions for articles
- Summary of a current article for an ASHI Q publication
4 Committee Vacancies (2) Doctoral and (2) Technologist positions
Technologists' Affairs Committee
- During Public Comment Period, review proposed changes to the standards and respond with comments
3 Committee Vacancies
ASHI Volunteer Form
- Submitting to the online Technologists' Forum
- Writing articles for ASHI quarterly
- Promoting ASHI on Social Media
Visit the Volunteer Portal
The performance and summary reports for the HT-1 are complete and are posted in the lab center. The AC-1 and EMO performance and summary reports will be posted soon. Login here to view.
The presentations are now available in ASHI University for just $10 each for ASHI members, and $20 each for non-members. They can be found in Volume 4.3:
While you're in ASHI-U, be sure to check out the updated Serum Preparation module, which can be found in Volume 1:
Log in to ASHI University
The next generation of Virtual Crossmatch is here!
VXmatch is a web and mobile-enabled application that displays all the crossmatch data you want; in exactly the way you want it. Want DSA trends, dilution, reactivity history, and graphs? VXmatch is a virtual crossmatch for labs who take it seriously.
Renew your 2017 ASHI membership today to avoid disruption of your ASHI benefits including a discounted meeting registration rate. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology.
|Has Your ASHI Membership Expired?
Renew Online Today!
The latest release of the 17th International Histocompatibility & Immunogenetics Workshop and Conference newsletter, IHIWS Connects, is now available. This issue features registration instructions for attending the 17th IHIWS in Pacific Grove, California, as well as important updates about the progress of workshop components and projects. To read this and all prior IHIWS Connects newsletters, visit: http://ihiws.org/newsletters/.
The 17th International Histocompatibility and Immunogenetics
Workshop and Workshop Conference
September 6–10, 2017
Asilomar Conference Grounds
800 Asilomar Ave
Pacific Grove, CA 93950
The registration fee includes:
Admission to all workshop sessions
Admission to all workshop social events
Welcome reception on 9/6
Closing "strolling dinner" reception on 9/9
44TH ANNUAL MEETING
October 1-5, 2018
Baltimore Marriott Waterfront
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
You must log in to access the members only Forums.
If you would like to receive updates as content is posted, you must subscribe by clicking the Forum Actions Box at the top of the Forum page and subscribe to instant updates or/and click to subscribe to the Digest to get updates.
Click here for detailed instructions
Why not join the conversation? Login here.
Current Forum topics being discussed include:
- HLA Laboratory Business Model
- Complement binding antibodies and 1:16 serum dilution
- DP Antibody in Heart Tx
- Justifying the need for another HLA tech
- Ongoing Poll! SAB Testing
- Contacting Patients for Serum Specimens
- NEW! Billing Questions: VXM, Hold & Freeze, & Mailers
- NEW! Repeat Mismatch
- What current challenges are you facing as a technologist?
- Ongoing Discussion! Easy Sep Bead Preparation for Flow Crossmatching
- How did you get started in HLA?
- NMDP codes
- Continuing Education
The detrimental impact of preformed anti-HLA donor-specific antibodies (DSA) is well defined, contrarily to non-donor-specific antibodies (NDSA). We sought to evaluate their clinical impact in a cohort of 724 kidney graft recipients in whom anti-HLA antibodies were thoroughly screened and identified in pre-transplant sera by solid-phase assays. NDSA or DSA were detected in 100 (13.8%) and 47 (6.5%) recipients respectively, while 577 (79.7%) were non-allosensitized (NaS).
By Chelsea Adams
Roughly 1 in 5 kidneys are thrown out each year in the United States. Kidneys are discarded if they are thought not to meet federal guidelines due to scarring or other issues. Many times, these kidneys are donated from older individuals who may have health problems. But a new study indicates that too many kidneys are discarded based only on biopsy results. Researchers say discarded kidneys could be more effective at keeping kidney failure patients alive than dialysis.
Centro Nacional de Investigaciones Cardiovasculares via ScienceDaily
Researchers have investigated how different subtypes of essential immune-response cells called CD8+
T lymphocytes cooperate to mount a stronger anti-tumor response. The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell — one circulating in the blood and the other resident in tissues — that can be reactivated with current immunotherapy strategies.
Dana-Farber Cancer Institute via Medical Xpress
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center — using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice — has revealed new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.
|Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063